BioCardia Files 8-K: Regulation FD, Other Events, Financials
Ticker: BCDA · Form: 8-K · Filed: Mar 31, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, corporate-event
Related Tickers: BCDA
TL;DR
BioCardia dropped an 8-K on 3/31 covering Reg FD, other events, and financials. Check it out.
AI Summary
BioCardia, Inc. filed an 8-K on March 31, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This 8-K filing provides updates on BioCardia's regulatory disclosures, significant events, and financial reporting, which are crucial for investors to understand the company's current status and compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard disclosures and events, not indicating any immediate financial distress or significant negative developments.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- March 31, 2025 (date) — Date of Report
- Tiger X Medical, Inc. (company) — Former Company Name
- Delaware (jurisdiction) — State of Incorporation
- Sunnyvale, California (location) — Principal Executive Offices
FAQ
What specific events are being disclosed under 'Other Events' in this 8-K filing?
The provided text does not detail the specific 'Other Events' but lists it as an item information category for the 8-K filing.
What is the SIC code for BioCardia, Inc. and what does it represent?
The SIC code for BioCardia, Inc. is 2836, which represents 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
When did BioCardia, Inc. change its name from Tiger X Medical, Inc.?
BioCardia, Inc. changed its name from Tiger X Medical, Inc. on June 16, 2011.
What is the fiscal year end for BioCardia, Inc.?
BioCardia, Inc.'s fiscal year ends on December 31.
What are the main sections of information reported in this 8-K filing?
This 8-K filing reports on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding BioCardia, Inc. (BCDA).